Literature DB >> 28404763

Why a One Size Fits All Approach to RAS Might Not Fit Colorectal Cancer.

Jonathan M Loree, Scott Kopetz.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28404763     DOI： 10.6004/jnccn.2017.0052

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Expression of Immuno-Oncologic Biomarkers Is Enriched in Colorectal Cancers and Other Solid Tumors Harboring the A59T Variant of KRAS.

Authors:  Emil Lou; Joanne Xiu; Yasmine Baca; Andrew C Nelson; Benjamin A Weinberg; Muhammad Shaalan Beg; Mohamed E Salem; Heinz-Josef Lenz; Philip Philip; Wafik S El-Deiry; W Michael Korn
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

2.  Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial.

Authors:  Jonathan M Loree; Anthony Dowers; Dongsheng Tu; Derek J Jonker; Daniel L Edelstein; Hannah Quinn; Frank Holtrup; Timothy Price; John R Zalcberg; Malcolm J Moore; Christos S Karapetis; Chris J O'Callaghan; Paul Waring; Hagen F Kennecke; Stanley R Hamilton; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2020-10-21       Impact factor: 13.801
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.